These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity. Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258 [TBL] [Abstract][Full Text] [Related]
6. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. Seebach JD; Comrack C; Germana S; LeGuern C; Sachs DH; DerSimonian H J Immunol; 1997 Oct; 159(7):3655-61. PubMed ID: 9317166 [TBL] [Abstract][Full Text] [Related]
7. A study of HLA-G1 protection of porcine endothelial cells against human NK cell cytotoxicity. Wang SS; Han JY; Wu XW; Cao RH; Qi HG; Xia ZX; Chen D; Gong FL; Chen S Transplant Proc; 2004 Oct; 36(8):2473-4. PubMed ID: 15561285 [TBL] [Abstract][Full Text] [Related]
8. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498 [TBL] [Abstract][Full Text] [Related]
9. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400 [TBL] [Abstract][Full Text] [Related]
10. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors. Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401 [TBL] [Abstract][Full Text] [Related]
11. HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity. Sasaki H; Xu XC; Smith DM; Howard T; Mohanakumar T Transplantation; 1999 Jan; 67(1):31-7. PubMed ID: 9921792 [TBL] [Abstract][Full Text] [Related]
12. Porcine aortic endothelial cells transfected with HLA-G are partially protected from xenogeneic human NK cytotoxicity. Forte P; Matter-Reissmann UB; Strasser M; Schneider MK; Seebach JD Hum Immunol; 2000 Nov; 61(11):1066-73. PubMed ID: 11137209 [TBL] [Abstract][Full Text] [Related]
13. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants. Carretero M; Palmieri G; Llano M; Tullio V; Santoni A; Geraghty DE; López-Botet M Eur J Immunol; 1998 Apr; 28(4):1280-91. PubMed ID: 9565368 [TBL] [Abstract][Full Text] [Related]
14. Natural killer cell recognition of HLA class I molecules. Brooks AG; Boyington JC; Sun PD Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749 [TBL] [Abstract][Full Text] [Related]
15. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484 [TBL] [Abstract][Full Text] [Related]
16. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Llano M; Lee N; Navarro F; García P; Albar JP; Geraghty DE; López-Botet M Eur J Immunol; 1998 Sep; 28(9):2854-63. PubMed ID: 9754572 [TBL] [Abstract][Full Text] [Related]
17. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets. Llano M; Gumá M; Ortega M; Angulo A; López-Botet M Eur J Immunol; 2003 Oct; 33(10):2744-54. PubMed ID: 14515258 [TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus UL18 alleviated human NK-mediated swine endothelial cell lysis. Kim JS; Choi SE; Yun IH; Kim JY; Ahn C; Kim SJ; Ha J; Hwang ES; Cha CY; Miyagawa S; Park CG Biochem Biophys Res Commun; 2004 Feb; 315(1):144-50. PubMed ID: 15013438 [TBL] [Abstract][Full Text] [Related]
20. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues. Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]